Correlation Engine 2.0
Clear Search sequence regions


  • anaphylaxis (1)
  • diagnosis (1)
  • humans (1)
  • marrow (2)
  • mast cell (11)
  • mastocytosis (2)
  • patients (1)
  • Sizes of these terms reflect their relevance to your search.

    The diagnosis of mast cell activation syndrome (MCAS) is defined by 3 criteria: (1) typical clinical signs and symptoms of acute, recurrent (episodic), and systemic mast cell activation (MCA); (2) increase in tryptase level to >20% + 2 ng/mL within 1-4 hours after onset of the acute crisis; and (3) response of MCA symptoms to antimediator therapy. Classification of MCAS requires highly sensitive and specific methodological approaches for the assessment of clonal bone marrow mast cells at low frequencies. The Spanish Network on Mastocytosis score has been used successfully as a predictive model for selecting MCAS candidates for bone marrow studies based on a high probability of an underlying clonal mast cell disorder. In this article, we propose a diagnostic algorithm and focus on the practical evaluation and management of patients with suspected MCAS.

    Citation

    A Matito, M M Escribese, N Longo, C Mayorga, O Luengo-Sánchez, M Pérez-Gordo, V Matheu, M Labrador-Horrillo, M Pascal, M E Seoane-Reula, Comité de Inmunología de la Sociedad Española de Alergología e Inmunología Clínica (SEAIC). Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview. Journal of investigational allergology & clinical immunology. 2021 Dec 21;31(6):461-470

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33541851

    View Full Text